Reuters Market Eye – Cipla drops 0.4 pct after July-Sept incomes. The drugmaker’s Q2 earnings fell 16 pct to 2.99 billion rupees ($48.6 million) on sluggish exports. Export sales in the quarter dropped by 4.6 percent, baseding on company presentation. Exports mostly attacked by greater slave consumption of basic materials, more focus on combination right into brand-new markets – Experts ($1 = 61.5900 rupees) (Reporting by Abhishek Vishnoi)Financial investment & & Company InformationFinanceCipla